Abstract:Age-related mobility decline is often associated with negative physical and psychological outcomes, such as frailty, in the elderly population. InC. elegans, during the early stage of the aging process, a progressive deficit of synaptic exocytosis in the motor neurons results in a functional decline at the neuromuscular junctions, which eventually leads to degeneration of both neurons and muscles. This age-dependent functional decline can be ameliorated by pharmacological interventions, such as arecoline, a muscarinic AChR agonist known to promote synaptic exocytosis at the neuromuscular junctions. In this study, we found that a short-term treatment of arecoline during the early stage of aging, when the NMJ functional decline begins, not only slows muscle tissue aging, but also extends lifespan inC. elegans. We have also demonstrated that arecoline acts on the GAR-2/PLC beta pathway in the motor neurons to increases longevity. Together, our findings suggest that synaptic transmission in aging motor neurons may serve as a potential target for pharmacological interventions to promote both health span and lifespan, when applied at the early stage aging. Impact statement The functional decline of motor activity is a common feature in almost all aging animals that leads to frailty, loss of independence, injury, and even death in the elderly population. Thus, understanding the molecular mechanism that drives the initial stage of this functional decline and developing strategies to increase human healthspan and even lifespan by targeting this process would be of great interests to the field. In this study, we found that by precisely targeting the motor neurons to potentiate its synaptic releases either genetically or pharmacologically, we can not only delay the functional aging at NMJs but also slow the rate of aging at the organismal level. Most importantly, we have demonstrated that a critical window of time, that is the early stage of NMJs functional decline, is required for the beneficial effects. A short-term treatment within this time period is sufficient to extend the animals' lifespan.

Identification and evaluation of midbrain specific longevity-related genes in exceptionally long-lived but healthy mice

Β-Nicotinamide Mononucleotide Supplementation Prolongs the Lifespan of Prematurely Aged Mice and Protects Colon Function in Ageing Mice.

Longitudinal autophagy profiling of the mammalian brain reveals sustained mitophagy throughout healthy aging

Recapitulation of anti-aging phenotypes by global overexpression of PTEN in mice

Geroprotective effects of Alzheimer's disease drug candidates

Partial inhibition of class III PI3K VPS-34 ameliorates motor aging and prolongs health span

Genetic Disruption of KLF1 K74 SUMOylation in Hematopoietic System Promotes Healthy Longevity in Mice

Delaying aging is neuroprotective in Parkinson’s disease: a genetic analysis in C. elegans models

Proteomic analysis of anti-aging effects of Dendrobium nobile Lindl. alkaloids in aging-accelerated SAMP8 mice

Biosystems Study of the Molecular Networks Underlying Hippocampal Aging Progression and Anti-aging Treatment in Mice.

Aging disrupts the coordination between mRNA and protein expression in mouse and human midbrain

Short-term enhancement of motor neuron synaptic exocytosis during early aging extends lifespan in<i>Caenorhabditis elegans</i>

JNK modifies neuronal metabolism to promote proteostasis and longevity

Dietary amelioration of locomotor, neurotransmitter and mitochondrial aging.

Microglial activation and age-related dopaminergic neurodegeneration in MPTP-treated SAMP8 mice.

Spermidine and spermine delay brain aging by inducing autophagy in SAMP8 mice

Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in Aged Mice

Hypothalamic gene transfer of BDNF promotes healthy aging in mice

Utilizing an Animal Model to Identify Brain Neurodegeneration-Related Biomarkers in Aging

Hypothalamic gene transfer of BDNF promotes healthy aging

Proteomic Profile of Mouse Brain Aging Contributions to Mitochondrial Dysfunction, DNA Oxidative Damage, Loss of Neurotrophic Factor, and Synaptic and Ribosomal Proteins